Thymopentin down-regulates both activity and expression of iNOS in blood cells of Sézary syndrome patients.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Nitric oxide

• Publication date

  2012-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.niox.2012.06.002PMID 22721692
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cutaneous lymphomas

  2014influential reference
• Protein data bank

  2012cited by this paper
• Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC).

  2011cited by this paper
• Open3DALIGN: an open-source software aimed at unsupervised ligand alignment

  2011cited by this paper
• LowModeMD - Implicit Low-Mode Velocity Filtering Applied to Conformational Search of Macrocycles and Protein Loops

  2010cited by this paper
• Targeting the L-arginine-nitric oxide pathway for cancer treatment.

  2010cited by this paper
• Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy.

  2010cited by this paper
• Biologically active conformations of thymopentin. Studies with conformationally restricted analogs.

  2009cited by this paper
• Drug development for orphan diseases in the context of personalized medicine.

  2009cited by this paper
• Genetic Polymorphisms in Nitric Oxide Synthase Genes Modify the Relationship between Vegetable and Fruit Intake and Risk of Non-Hodgkin Lymphoma

  2009cited by this paper
• Why rare diseases are an important medical and social issue.

  2008cited by this paper
• Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).

  2007cited by this paper
• Cutaneous lymphomas.

  2007cited by this paper
• Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.

  2006influential reference
• Role of nitric oxide in the regulation of T cell functions

  2006cited by this paper
• Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome

  2005cited by this paper
• Nitric Oxide, a Mediator of Inflammation, Suppresses Tumorigenesis

  2004cited by this paper
• Is inducible nitric oxide synthase a target for chemoprevention?

  2003cited by this paper
• Differential expression of protein kinase C isoenzymes related to high nitric oxide synthase activity in a T lymphoma cell line.

  2002cited by this paper
• Nitric oxide synthase assays.

  2001cited by this paper
• The Protein Data Bank

  2000cited by this paper
• Immunosuppressory mini-regions of HLA-DP and HLA-DR.

  1999cited by this paper
• Assay of NOS activity by the measurement of conversion of oxyhemoglobin to methemoglobin by NO.

  1998cited by this paper
• Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor.

  1997cited by this paper
• Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis.

  1996cited by this paper
• Nitric oxide: a new paradigm for second messengers.

  1995cited by this paper
• Nitric oxide synthases: roles, tolls, and controls.

  1994cited by this paper
• Nitric-oxide synthase assays.

  1994cited by this paper
• The arginine‐nitric oxide pathway: A target for new drugs

  1994cited by this paper
• Characterization of the immunosuppressive effects of nitric oxide in graft vs host disease.

  1993cited by this paper
• Thymopentin in Sézary syndrome.

  1992cited by this paper
• In vivo enhancement of NK-cell activity by thymopentin.

  1990cited by this paper
• A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin.

  1979cited by this paper
• Solid-phase peptide synthesis.

  1977cited by this paper
• Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

  1970cited by this paper

• Thymopentin-Mediated Inhibition of Cancer Stem Cell Stemness Enhances the Cytotoxic Effect of Oxaliplatin on Colon Cancer Cells

  2022cites this paper
• The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations

  2021cites this paper
• Biobased dynamic hydrogels by reversible imine bonding for controlled release of thymopentin.

  2021cites this paper
• Facile preparation of superparamagnetic surface-imprinted microspheres using amino acid as template for specific capture of thymopentin

  2015cites this paper
• Superparamagnetic Molecularly Imprinting Polymers for Adsorbent and Separation Pentapeptides by Surface ATRP

  2015cites this paper
• Associations between the Antioxidant Network and Emotional Intelligence: A Preliminary Study

  2014cites this paper
• Preparation and Recognition Characteristics of Thymopentin Molecularly Imprinted Polymers on SiO2

  2014cites this paper
• Thymopentin Magnetic Molecularly Imprinted Polymers with Room Temperature Ionic Liquids as a Functional Monomer by Surface-Initiated ATRP

  2014cites this paper